Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 439-444

  Vilchez, F ^a   Martinez Pastor J C ^a   Garcia Ramiro S ^a   Bori, G ^a   Macule F ^a   Sierra, J ^a   Font, L ^a   Mensa, J ^a   Soriano, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Infection; Joint; Outcome; Risk factors; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CEFTAZIDIME; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; LEVOFLOXACIN; LINEZOLID; METICILLIN; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; DEMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HIP HEMIARTHROPLASTY; HIP PROSTHESIS; HUMAN; INFECTION CONTROL; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHETIC JOINT INFECTION; REINFECTION; RELAPSE; REMISSION; STAPHYLOCOCCUS AUREUS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; TREATMENT FAILURE;

STAPHYLOCOCCUS AUREUS;

EID: 79751512871     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03244.x     Document Type: Article

References (22)

1. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am 2003; 85-A (suppl 1):S75-S80.
2. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654.
3. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-1218.
4. Javaloyas DM, Monreal PM. Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up. Med Clin (Barc) 1999; 113: 488-489.
5. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1251-1253.
6. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 1998; 279: 1537-1541.
7. Barberan J, Aguilar L, Carroquino G et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006; 119: 993-10.
8. Soriano A, Garcia S, Bori G et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006; 12: 930-933.
9. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-919.
10. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12: 433-439.
11. Morris AB, Kanyok TP, Scott J, Peloquin Ch, Berning SE. Rifamycins. In: Yu VL, Merigan TC, Barriere SL, eds, Antimicrobial therapy and vaccines. Pennsylvania: Williams & Wilkins, 1999; 901-962.
12. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47: 1251-1256.
13. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002; 44: 319-324.
14. Betsch BY, Eggli S, Siebenrock KA, Tauber MG, Muhlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008; 46: 1221-1226.
15. Byren I, Bejon P, Atkins BL et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63: 1264-1271.
16. Berdal JE, Skramm I, Mowinckel P, Gulbrandsen P, Bjornholt JV. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005; 11: 843-845.
17. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
18. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-967.
19. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007; 55: 1-7.
20. Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007; 461: 48-53.
21. Soriano A, Gomez J, Gomez L et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007; 26: 353-356.
22. Bassetti M, Vitale F, Melica G et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother 2005; 55: 387-390.